{"id":2860,"date":"2007-11-23T12:51:40","date_gmt":"2007-11-23T10:51:40","guid":{"rendered":"http:\/\/www.ced.org.tr\/?p=2860"},"modified":"2014-05-21T01:40:24","modified_gmt":"2014-05-20T22:40:24","slug":"jenerik-ilac-fiyatlari-gercek-maliyet-uzerinden-hesaplanmalidir","status":"publish","type":"post","link":"http:\/\/www.ced.org.tr\/?p=2860","title":{"rendered":"JENER\u0130K \u0130LA\u00c7 F\u0130YATLARI GER\u00c7EK MAL\u0130YET \u00dcZER\u0130NDEN HESAPLANMALIDIR"},"content":{"rendered":"

Sermayenin k\u00fcreselle\u015fmesi sonucu en \u00f6nemli sekt\u00f6rlerden biri olan uluslararas\u0131 ila\u00e7 sekt\u00f6r\u00fc \u00fclkemizi y\u0131llar \u00f6nce pazar\u0131 en fazla b\u00fcy\u00fcyecek \u00fc\u00e7 aday \u00fclkeden biri olarak g\u00f6stermi\u015ftir. Ve ki\u015fi ba\u015f\u0131 ila\u00e7 harcamalar\u0131n\u0131n da olmas\u0131 gerekenin \u00e7ok alt\u0131nda oldu\u011funu s\u00f6yleyerek, T\u00fcrkiye ila\u00e7 pazar\u0131ndaki hedeflerini \u201c2015 y\u0131l\u0131nda 30 milyar dolar\u201d<\/strong> olarak saptam\u0131\u015flard\u0131r. Fakat zaman\u0131n \u00c7al\u0131\u015fma ve Sosyal G\u00fcvenlik Bakan\u0131 Ya\u015far Okuyan, 15 \u015eubat 2002 tarihinde Ba\u011f-Kur\u2019da e\u015fde\u011fer ila\u00e7 uygulamas\u0131n\u0131 ba\u015flatmas\u0131n\u0131n ard\u0131ndan, 1 Mart 2003 tarihinde Emekli Sand\u0131\u011f\u0131\u2019n\u0131n da ortalama fiyat uygulamas\u0131na ge\u00e7mesi, bunlar\u0131n tekerine \u00e7omak soktu.<\/span><\/p>\n

\u00a0<\/p>\n

Bunun \u00fczerine yabanc\u0131 ila\u00e7 firmalar\u0131, Amerika\u2019da PhRMA (Amerikan Ara\u015ft\u0131rmac\u0131 \u0130la\u00e7 \u00dcreticileri Birli\u011fi), Avrupa\u2019da da EFPIA\u2019y\u0131 (Avrupa Farmas\u00f6tik End\u00fcstri ve Dernekleri Federasyonu) devreye sokarak T\u00fcrkiye\u2019deki h\u00fck\u00fcmet \u00fczerinde bask\u0131lar kurdular.<\/span><\/p>\n

\u00a0<\/p>\n

Amerikan PhRMA \u201cUygulamalar devam ederse yeni geli\u015ftirdikleri hayati ila\u00e7lar\u0131 T\u00fcrkiye\u2019ye vermeyeceklerini, T\u00fcrkiye\u2019deki yat\u0131r\u0131mlar\u0131 durduracaklar\u0131n\u0131, olan yat\u0131r\u0131mlar\u0131 da geri \u00e7ekeceklerini\u201d<\/strong> s\u00f6yledi.<\/span><\/p>\n

\u00a0<\/p>\n

AB Komisyonu ise 2003 y\u0131l\u0131nda \u201c\u015eeffaf olmayan, ayr\u0131m g\u00f6zeten ve ticarette k\u0131s\u0131tlama getiren uygulamalarla T\u00fcrkiye H\u00fck\u00fcmetinin, WTO (D\u00fcnya Ticaret \u00d6rg\u00fct\u00fc), GATTS ve TR\u0130PS anla\u015fmalar\u0131n\u0131 ihlal etti\u011fini\u201d<\/strong> s\u00f6yleyerek, T\u00fcrkiye h\u00fck\u00fcmetine bu uygulamalar\u0131n kald\u0131r\u0131lmas\u0131 ve veri imtiyaz\u0131 uygulamalar\u0131na derhal ge\u00e7ilmesi i\u00e7in bir \u00fcltimatom g\u00f6nderdi. <\/span><\/p>\n

\u00a0<\/p>\n

\u0130la\u00e7 End\u00fcstrisi \u0130\u015fverenler Sendikas\u0131 (\u0130E\u0130S) Ba\u015fkan\u0131 B\u00fclent Eczac\u0131ba\u015f\u0131 da o d\u00f6nemde T\u00fcrkiye\u2019de \u00fcretilen jenerik ila\u00e7lar i\u00e7in \u201cikinci kalite\u201d<\/strong> hatta \u201csahte\u201d<\/strong> ila\u00e7 var diyerek, o kesimlere destek verip yerli ila\u00e7 sanayiini \u015faibeli duruma d\u00fc\u015f\u00fcrm\u00fc\u015ft\u00fcr. Bu geli\u015fmeler sonucu, Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131\u2019nca jenerik ila\u00e7larda biyoe\u015fde\u011ferlilik \u00e7al\u0131\u015fmas\u0131 istenmi\u015f, yerli ila\u00e7 firmalar\u0131na b\u00fcy\u00fck maliyet getiren, \u00e7o\u011fu yurtd\u0131\u015f\u0131nda yap\u0131lan biyoe\u015fde\u011ferlilik \u00e7al\u0131\u015fmalar\u0131 sonucu, d\u00fcnya ortalamas\u0131n\u0131n (d\u00fcnyada %3) alt\u0131nda hata bulunmu\u015ftur. Bu da T\u00fcrkiye\u2019de ikinci kalite ve sahte ila\u00e7 olmad\u0131\u011f\u0131n\u0131 g\u00f6stermi\u015ftir. Bug\u00fcn \u0130E\u0130S utanmadan, Temmuz 2007 b\u00fclteninde; \u201cyap\u0131lan kontroller sonucu, biyoe\u015fde\u011fer olmad\u0131\u011f\u0131 belirlenerek piyasadan \u00e7ekilen \u00fcr\u00fcn olmam\u0131\u015ft\u0131r\u201d<\/strong> diyebilmektedir.<\/span><\/p>\n

\u00a0<\/p>\n

Bu s\u0131ralarda kriz ya\u015fayan Ecevit h\u00fck\u00fcmetinin erken se\u00e7im karar\u0131 almas\u0131 sonucu iktidara gelen ABD destekli AKP h\u00fck\u00fcmeti, D\u00fcnya Bankas\u0131 projesi sa\u011fl\u0131kta d\u00f6n\u00fc\u015f\u00fcm<\/strong> program\u0131n\u0131 hayata ge\u00e7irdi. <\/span><\/p>\n

\u00a0<\/p>\n

2004 y\u0131l\u0131ndan itibaren AKP h\u00fck\u00fcmetince, sa\u011fl\u0131kta reform ad\u0131 alt\u0131nda ba\u015flat\u0131lan d\u00f6n\u00fc\u015f\u00fcm sonucu ila\u00e7 t\u00fcketimi katlanarak artt\u0131. Bu uygulama ile T\u00fcrkiye\u2019de pazardaki ila\u00e7lar\u0131n %85\u2019inin devlet taraf\u0131ndan sat\u0131n al\u0131nmas\u0131, devletin ila\u00e7 harcamas\u0131n\u0131 da b\u00fcy\u00fck oranda art\u0131rd\u0131. Devlet tasarruf ama\u00e7l\u0131 jenerik ila\u00e7 uygulamas\u0131n\u0131 benimsedi ve bu uygulama, orijinal ila\u00e7 a\u011f\u0131rl\u0131kl\u0131 yabanc\u0131 firmalar\u0131n kurumlara ila\u00e7 sat\u0131\u015flar\u0131n\u0131n b\u00fcy\u00fck miktarda azalmas\u0131na sebep oldu.<\/span><\/p>\n

\u00a0<\/p>\n

Uluslararas\u0131 ila\u00e7 sermayesi dev ila\u00e7 \u015firketlerini yaratt\u0131ktan sonra, son y\u0131llarda \u00fclkemizdeki yerli ila\u00e7 firmalar\u0131n\u0131 da sat\u0131n almaya ba\u015flad\u0131. Bug\u00fcn birka\u00e7 yerli ila\u00e7 firmas\u0131 d\u0131\u015f\u0131nda yerli ila\u00e7 firmalar\u0131 yabanc\u0131lar\u0131n eline ge\u00e7mi\u015f durumdad\u0131r. Bunlar\u0131n bir k\u0131sm\u0131 da \u015firket merkezlerini okyanus adalar\u0131ndan g\u00f6steren Amerikan finans \u015firketleridir<\/strong>. <\/span><\/p>\n

\u00a0<\/p>\n

Ba\u015fta Eczac\u0131ba\u015f\u0131 olmak \u00fczere devletten ald\u0131klar\u0131 te\u015fviklerle (bedelsiz veya ucuz arazi ve sigorta muafiyeti vesaire) ve ayr\u0131ca eczac\u0131lar\u0131n b\u00fcy\u00fck deste\u011fiyle (yabanc\u0131 ila\u00e7 yerine yerli e\u015fde\u011ferinin verilmesi) bug\u00fcnk\u00fc b\u00fcy\u00fckl\u00fcklerine gelen yerli ila\u00e7 firmalar\u0131, bu \u00fclkenin yaratt\u0131\u011f\u0131 de\u011ferleri, sanki kendi ticari ba\u015far\u0131lar\u0131ym\u0131\u015f gibi g\u00f6sterip kendilerince \u00e7ok iyi fiyatlarla firmalar\u0131n\u0131 satm\u0131\u015flard\u0131r ve yapt\u0131klar\u0131 al\u0131\u015fveri\u015ften dolay\u0131 \u00f6v\u00fcnmektedirler.<\/span><\/p>\n

\u00a0<\/p>\n

Yerli ila\u00e7 firmalar\u0131, \u015firketlerinin tamam\u0131n\u0131, ya da b\u00fcy\u00fck bir k\u0131sm\u0131n\u0131 satm\u0131\u015f olmalar\u0131na ra\u011fmen, art\u0131k yabanc\u0131lara ait olan jenerik ila\u00e7lar\u0131n sat\u0131\u015f\u0131n\u0131 sanki kendi yerli ila\u00e7lar\u0131ym\u0131\u015f gibi te\u015fvik etmek \u00e7abas\u0131ndad\u0131rlar. <\/span><\/p>\n

\u00a0<\/p>\n

Asl\u0131nda burada b\u00fcy\u00fck bir soygun vard\u0131r.<\/span><\/span><\/span><\/strong><\/p>\n

Olay \u015fudur!<\/span><\/span><\/span><\/strong><\/p>\n

\u00a0<\/span><\/span><\/span><\/strong>\u00a0<\/p>\n

2004 y\u0131l\u0131 \u00f6ncesi ucuz e\u015fde\u011fer ve referans uygulamas\u0131 sonucu bir\u00e7ok orijinal ilac\u0131n\u0131 (\u00f6rne\u011fin Norvasc) devlete satamayan yabanc\u0131 firmalar (orijinal ila\u00e7lar ile jenerikler aras\u0131nda ortalama %50\u2019ye yak\u0131n fiyat fark\u0131 var) yukar\u0131da isimlerini s\u00f6yledi\u011fimiz (PhRMA-EFPIA gibi) kendi kurulu\u015flar\u0131 ile ABD ve AB h\u00fck\u00fcmetlerine bask\u0131lar yaparak T\u00fcrkiye\u2019deki AKP h\u00fck\u00fcmetine 2004 \u0130la\u00e7 Fiyat Kararnamesini<\/strong> \u00e7\u0131kartt\u0131rm\u0131\u015flard\u0131r. Bu kararname ile, Avrupa\u2019n\u0131n en ucuz 5 \u00fclkesinin fiyatlar\u0131 baz al\u0131narak orijinal ila\u00e7lar\u0131n fiyatlar\u0131 Euro\u2019ya endekslenmi\u015ftir.<\/span><\/p>\n

\u00a0<\/p>\n

Ama esas yapt\u0131klar\u0131 i\u015f jenerik ila\u00e7 fiyatlar\u0131n\u0131n hi\u00e7bir k\u0131s\u0131tlama veya maliyet unsuru g\u00f6zetmeksizin orijinal ilac\u0131n %80\u2019i kadar fiyat\u0131 otomatikman almas\u0131d\u0131r.<\/span><\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

D\u00fcnyada ortalama jenerik ila\u00e7 fiyat\u0131, orijinalinin ilac\u0131n %50\u2019si kadard\u0131r. (%20 ila %80 aras\u0131) \u00dclkemize bak\u0131ld\u0131\u011f\u0131nda, bu kararname sonucu jenerik ila\u00e7lar \u00fczerinden en az\u0131ndan ortalama %30 haks\u0131z kazan\u00e7 elde edilmektedir.<\/span><\/p>\n

\u00a0<\/p>\n

Ayr\u0131ca \u00fclkemizde patent yasas\u0131 \u00f6ncesi ruhsat alm\u0131\u015f olan jenerik ila\u00e7lar, Avrupa ve ABD\u2019de orijinalinin patent korumas\u0131nda olmas\u0131 nedeniyle \u00fcretilememektedir. Yerli ila\u00e7 firmalar\u0131n\u0131 sat\u0131n alan yabanc\u0131lar, bu t\u00fcr jenerik ila\u00e7lar\u0131 da T\u00fcrkiye\u2019de \u00fcretip, i\u00e7 ve d\u0131\u015f pazarlara satma imkan\u0131n\u0131 da elde etmi\u015f oldular. Asl\u0131nda bir\u00e7ok firma da bu nedenle sat\u0131n al\u0131nm\u0131\u015ft\u0131r. <\/span><\/p>\n

\u00a0<\/p>\n

\u00dclkemizde imal edilen ve b\u00fct\u00fcn girdileri ve maliyet unsurlar\u0131 bilinen jenerik \u00fcr\u00fcnler neden ger\u00e7ek de\u011feri \u00fczerinden fiyatland\u0131r\u0131lmaz. Olay a\u00e7\u0131k, e\u011fer b\u00f6yle fiyatland\u0131r\u0131l\u0131rsa beylerin orijinal ila\u00e7lar\u0131 geri \u00f6deme listelerine giremez ve sat\u0131\u015flar\u0131 dibe vurur. \u00d6yle yapaca\u011f\u0131na \u00f6nce jenerik \u00fcr\u00fcnlere haks\u0131z bir \u015fekilde orijinalinin %80\u2019i fiyat verirsin, sonra o yerli firmalar\u0131 de\u011ferinin \u00fczerinde fiyatlar vererek bir bir sat\u0131n al\u0131rs\u0131n, \u00f6nceleri bunu mal fazlas\u0131na yans\u0131t\u0131p belli kesimleri susturursun, daha sonra yava\u015f yava\u015f mal fazlas\u0131 ve \u0131skontolar\u0131 geri \u00e7ekerek yerli firma sahiplerine verdi\u011fin paralar\u0131 katmeriyle geri al\u0131rs\u0131n.<\/strong><\/span><\/span><\/span><\/p>\n

<\/strong><\/span><\/span><\/span>\u00a0<\/p>\n

Devlete hem orijinalini sat\u0131p k\u00e2r edersin, hem de 2004 \u00f6ncesi toplu pazarl\u0131kla devlete \u00e7ok ucuz sat\u0131lan jenerik ila\u00e7lar\u0131 hamutuyla devlete yutturursun, ayr\u0131ca patent korumas\u0131 nedeniyle AB ve ABD\u2019de \u00fcretemedi\u011fin ila\u00e7lar\u0131 \u00fcreterek i\u00e7 ve d\u0131\u015f piyasalara satars\u0131n. Zaman i\u00e7erisinde yerli firmalar\u0131 imalat merkezi olmaktan \u00e7\u0131kar\u0131p AR-GE merkezi haline getirirsin, h\u00fck\u00fcmetten \u00fcniversite hastanelerine yat\u0131r\u0131mlar yapt\u0131rarak \u00fcniversiteler ile \u015firketler aras\u0131nda ba\u011flant\u0131lar kurar, T\u00fcrkiye\u2019de insanlar \u00fczerinde yeni ila\u00e7lar\u0131 denersin. (Bkz: \u2018Avrupa ve ABD\u2019li ila\u00e7\u00e7\u0131lar T\u00fcrk firmalar\u0131n\u0131n pe\u015finde\u2019, Sabah, 10 Kas\u0131m 2007)<\/span><\/span><\/span><\/strong><\/p>\n

<\/span><\/span><\/strong>\u00a0<\/p>\n

Bu arada Sosyal G\u00fcvenlik Kurumu\u2019nun a\u00e7\u0131klar\u0131 art\u0131yormu\u015f, \u00f6deme dengeleri bozuluyormu\u015f, senin h\u00fck\u00fcmetin bu a\u00e7\u0131klar\u0131 kapatmak i\u00e7in \u00fclke kaynaklar\u0131n\u0131, stratejik, k\u00e2r eden kurulu\u015flar\u0131n\u0131 bir bir babalar gibi sat\u0131yormu\u015f, ayr\u0131ca d\u00fcnyada ortalama bor\u00e7lanma faizi %3 iken, d\u00fcnyan\u0131n en y\u00fcksek faizleriyle (%15) d\u0131\u015f d\u00fcnyaya bor\u00e7lan\u0131yormu\u015f, \u00fclke b\u00fct\u00e7esinin b\u00fcy\u00fck b\u00f6l\u00fcm\u00fc bu faiz \u00f6demelerine gidiyormu\u015f kimin umurunda! (Bu da d\u0131\u015f sermaye gruplar\u0131n\u0131n g\u00fcvendi\u011fi istikrarl\u0131 \u00fclke hikayesiyle yap\u0131l\u0131yor.) 2002\u2019de 170 milyar dolar olan \u00fclkenin toplam borcu 2007\u2019de 447 milyar dolara \u00e7\u0131km\u0131\u015f, d\u0131\u015f ticaret a\u00e7\u0131\u011f\u0131 her y\u0131l rekorlar k\u0131r\u0131yormu\u015f ne gam!<\/span><\/p>\n

\u00a0<\/p>\n

T\u00fcrk Eczac\u0131lar\u0131 Birli\u011fi (TEB) 2004 ila\u00e7 fiyat kararnamesini \u00e7\u0131kt\u0131\u011f\u0131 anda sahiplenmi\u015f ve bir devrim olarak nitelendirmi\u015ftir. \u0130la\u00e7 i\u015fverenleri ise gazetelere ilanlar vererek yeni fiyat kararnamesi i\u00e7in h\u00fck\u00fcmete te\u015fekk\u00fcrler etmi\u015flerdir. Sa\u011fl\u0131kta D\u00f6n\u00fc\u015f\u00fcm Program\u0131n\u0131n en \u00f6nemli a\u015famas\u0131 ayaktan tedavide ila\u00e7lar\u0131n serbest eczanelerden verilmesidir. TEB bu uygulaman\u0131n altyap\u0131s\u0131 haz\u0131r olmad\u0131\u011f\u0131 halde, sistemin t\u00fcm s\u0131k\u0131nt\u0131lar\u0131n\u0131 eczac\u0131lara y\u00fckleyen protokol\u00fc derhal hayata ge\u00e7irerek, sa\u011fl\u0131kta d\u00f6n\u00fc\u015f\u00fcm\u00fcn siyasal rant\u0131n\u0131n h\u00fck\u00fcmet\u00e7e toplanmas\u0131na ve se\u00e7imlerde b\u00fcy\u00fck oy art\u0131\u015f\u0131 sa\u011flamas\u0131na yard\u0131mc\u0131 olmu\u015ftur. TEB Ba\u015fkan\u0131 da verdi\u011fi hizmetler kar\u015f\u0131l\u0131\u011f\u0131nda milletvekili yap\u0131larak \u00f6d\u00fcllendirilmi\u015ftir.<\/span><\/p>\n

\u00a0<\/p>\n

Peki, \u0130la\u00e7 End\u00fcstrisi \u0130\u015fverenler Sendikas\u0131\u2019na (\u0130E\u0130S) ne dersiniz?<\/span><\/p>\n

TEB\u2019i ve T\u00fcm Eczac\u0131 Kooperatifleri Birli\u011fi\u2019ni (TEKB) yan\u0131na alm\u0131\u015f, onlar\u0131n deste\u011fiyle jenerik ila\u00e7 ata\u011f\u0131na kalkm\u0131\u015f, son y\u0131llarda her toplant\u0131da neredeyse jenerik ila\u00e7la yat\u0131p jenerik ila\u00e7la kalk\u0131yor. <\/span><\/p>\n

\u00a0<\/p>\n

Ne diyor: \u201cE\u015fde\u011fer ila\u00e7 kullan\u0131m\u0131n\u0131n te\u015fvik edilmesi, bug\u00fcn pek \u00e7ok geli\u015fmi\u015f \u00fclkede bir devlet politikas\u0131 olarak uygulan\u0131yor. E\u015fde\u011fer ila\u00e7lar\u0131n kamu maliyesine ve hastalar\u0131n b\u00fct\u00e7esine sa\u011flad\u0131\u011f\u0131 faydalar, yap\u0131lan ara\u015ft\u0131rmalardan elde edilen somut verilerle a\u00e7\u0131k\u00e7a g\u00f6r\u00fcl\u00fcyor. \u0130la\u00e7 End\u00fcstrisi \u0130\u015fverenler Sendikas\u0131 olarak, e\u015fde\u011fer ila\u00e7lar\u0131n kullan\u0131m\u0131n\u0131n yayg\u0131nla\u015ft\u0131r\u0131lmas\u0131 konusunda etkin \u00e7al\u0131\u015fmalar y\u00fcr\u00fct\u00fcyoruz.\u201d A\u011f\u0131rl\u0131kl\u0131 olarak \u201cbilgilendirme\u201d amac\u0131 ta\u015f\u0131yan \u00e7al\u0131\u015fmalar \u201cE\u015eDE\u011eER \u0130LA\u00c7 KAMPANYASI\u201d \u00e7at\u0131s\u0131 alt\u0131nda toplan\u0131yor.<\/strong><\/span><\/span><\/span><\/p>\n

<\/strong><\/span><\/span><\/span>\u00a0<\/p>\n

B\u00fclent Eczac\u0131ba\u015f\u0131 bunu ne zaman s\u00f6yl\u00fcyor? Yerli ila\u00e7 firmas\u0131 Eczac\u0131ba\u015f\u0131\u2019n\u0131n %75\u2019ini, b\u00fcy\u00fck orta\u011f\u0131 NOVART\u0130S olan Zentiva adl\u0131 jenerik firmas\u0131na sat\u0131p ald\u0131\u011f\u0131 paralar ile yurtd\u0131\u015f\u0131nda seramik fabrikas\u0131 sat\u0131n ald\u0131ktan sonra s\u00f6yl\u00fcyor. Yurtd\u0131\u015f\u0131na d\u00f6viz g\u00f6t\u00fcr\u00fcyor.<\/span><\/p>\n

\u00a0<\/p>\n

Daha ne diyor \u00fcstat:<\/span><\/p>\n

\u201cT\u00fcrkiye, \u00fcretti\u011fi ila\u00e7lar\u0131n\u0131n kalitesi, etkinli\u011fi ve g\u00fcvenilirli\u011fiyle bir\u00e7ok \u00fclke pazar\u0131nda yer almaktad\u0131r. Son derece modern, uluslararas\u0131 standartlarda \u00fcretim yapan tesislerimizin uluslararas\u0131 onay alm\u0131\u015f ve alabilecek d\u00fczeyde olmalar\u0131 ila\u00e7 end\u00fcstrimizin ihracata d\u00f6n\u00fck \u00e7al\u0131\u015fmalar\u0131 i\u00e7in \u00e7ok \u00f6nemli potansiyeldir.\u201d<\/span><\/span><\/span><\/strong><\/p>\n

<\/span><\/span><\/strong>\u00a0<\/p>\n

Adama sormazlar m\u0131?<\/span><\/p>\n

Bu bahsetti\u011fin tesisler daha 3-4 y\u0131l \u00f6nce \u201cikinci kalite\u201d hatta \u201csahte ila\u00e7\u201d \u00fcretiyordu. O zaman ila\u00e7 fiyatlar\u0131nda k\u0131smen ger\u00e7ek maliyet vard\u0131, sahipleri de yerli idi. O zaman ikinci s\u0131n\u0131ft\u0131 da, 2004 fiyat kararnamesiyle y\u00fcksek fiyat al\u0131nca ve sahipleri de yabanc\u0131 olunca m\u0131 birinci s\u0131n\u0131f tesisler ve birinci s\u0131n\u0131f ila\u00e7lar oldular?<\/span><\/p>\n

\u00a0<\/p>\n

Peki, \u00fcstat ba\u015fka ne istiyor:<\/span><\/p>\n

\u201c\u0130la\u00e7 end\u00fcstrimizin yap\u0131s\u0131na ve \u00fclkemizin ko\u015fullar\u0131na uygun TE\u015eV\u0130K MODELLER\u0130N\u0130N uygulamaya konmas\u0131yla, e\u015fde\u011fer ila\u00e7 kullan\u0131m\u0131yla sa\u011flanan tasarruf miktar\u0131n\u0131n artaca\u011f\u0131na ve end\u00fcstrimizin<\/strong> (hangisi bizim? \u2013S.G.) rekabet g\u00fcc\u00fcn\u00fcn y\u00fckselece\u011fine inan\u0131yoruz.\u201d<\/strong><\/span><\/span><\/span><\/p>\n

<\/strong><\/p>\n

\u201cMevzuatlarla ilgili sorunlar a\u015f\u0131labilirse T\u00fcrkiye\u2019nin geli\u015fen d\u00fcnya e\u015fde\u011fer ila\u00e7 pazar\u0131nda \u00f6nemli bir oyuncu olmas\u0131 sa\u011flanabilir.\u201d<\/strong> diyor.<\/span><\/span><\/span><\/p>\n

\u00a0<\/p>\n

Beyefendiler yine devlet kap\u0131s\u0131ndalar. Yine te\u015fvik istiyorlar yine mevzuat de\u011fi\u015fikli\u011fi istiyorlar. Kimin ad\u0131na? Novartis ortakl\u0131 Zentiva\u2019ya satt\u0131klar\u0131 yabanc\u0131lar i\u00e7in mi? \u00c7abalar\u0131 yoksa b\u00fcy\u00fck okyanustaki adalar\u0131 merkez edinmi\u015f yabanc\u0131 \u015firketler i\u00e7in mi?<\/span><\/p>\n

\u00a0<\/p>\n

30.06.2007 tarihinde yeniden d\u00fczenlenen ila\u00e7 fiyat kararnamesinin, yay\u0131nlanan tebli\u011finin 5. maddesinin (c) f\u0131kras\u0131 aynen \u015f\u00f6yledir: \u201cRe\u00e7etesiz ila\u00e7lar i\u00e7in karar\u0131n en ucuz referans fiyat sistemi i\u015fletilmez. Bu \u00fcr\u00fcnler i\u00e7in orijinal ya da jenerik olmas\u0131na bak\u0131lmaks\u0131z\u0131n i\u015flem yap\u0131l\u0131r. Talep edilecek fiyat referans \u00fclkelerde \u00fcr\u00fcn\u00fcn mevcut en y\u00fcksek resmi depocuya sat\u0131\u015f fiyat\u0131ndan y\u00fcksek olamaz. Bu \u00fcr\u00fcnlerin fiyatlar\u0131 her y\u0131l yeniden g\u00f6zden ge\u00e7irilir.\u201d<\/strong> Re\u00e7etesiz jenerik ila\u00e7lar\u0131n fiyatlar\u0131n\u0131n serbest b\u0131rak\u0131lmas\u0131 resmen hayata ge\u00e7iriliyor.<\/span><\/p>\n

\u00a0<\/p>\n

Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 \u0130la\u00e7 ve Eczac\u0131l\u0131k Genel M\u00fcd\u00fcr\u00fc Say\u0131n Mahmut Toka\u00e7; \u201cRe\u00e7eteli ila\u00e7lar\u0131n eczanelerden re\u00e7etesiz sat\u0131lmas\u0131na kesinlikle m\u00fcsaade edilmeyecektir. Re\u00e7eteli ila\u00e7larda reklam kesinlikle yap\u0131lamaz. Ancak re\u00e7etesiz ila\u00e7larda s\u0131n\u0131rl\u0131 ve kontroll\u00fc bir \u015fekilde halka tan\u0131t\u0131ma \u2026\u201d<\/strong> diyerek eczac\u0131n\u0131n OTC uygulamalar\u0131na tepki g\u00f6stermemesi i\u00e7in aba alt\u0131ndan sopa g\u00f6steriyor. Reklam\u0131 da g\u00f6nl\u00fc istiyor ama Dan\u0131\u015ftay karar\u0131na tak\u0131l\u0131yor. <\/span><\/p>\n

\u00a0<\/p>\n

\u0130E\u0130S; TEB ve TEKB\u2019yi yan\u0131na alarak her platformda beraberce jenerik ila\u00e7 kullan\u0131m\u0131n\u0131n art\u0131r\u0131lmas\u0131n\u0131 istiyor. Ayn\u0131 zamanda \u00dcniversitelerin T\u0131p, Eczac\u0131l\u0131k, Di\u015f Hekimli\u011fi Fak\u00fcltelerinde \u00f6\u011frencilerle yap\u0131lan toplant\u0131lar da bu amac\u0131 g\u00fctmektedir. <\/span><\/p>\n

\u00a0<\/p>\n

\u0130E\u0130S asl\u0131nda ila\u00e7lar\u0131n re\u00e7eteli ve re\u00e7etesiz olarak ayr\u0131lmas\u0131n\u0131 ve re\u00e7etesiz ila\u00e7lar\u0131n fiyatlar\u0131n\u0131n serbest b\u0131rak\u0131lmas\u0131n\u0131 ve reklam serbestli\u011fiyle y\u00fcksek fiyattan sat\u0131\u015flar\u0131n\u0131 art\u0131rarak, \u00e7okuluslu \u015firketlerin T\u00fcrkiye \u00fczerinde ger\u00e7ekle\u015ftirmeyi d\u00fc\u015f\u00fcnd\u00fckleri ila\u00e7 pazar\u0131n\u0131 yaratmaya \u00e7al\u0131\u015f\u0131yor.<\/span><\/span><\/span><\/strong><\/p>\n

<\/span><\/span><\/strong>\u00a0JENER\u0130K \u0130LA\u00c7LARIN SATI\u015eINI B\u0130Z DE DESTEKL\u0130YORUZ, AMA \u00d6NCE YERL\u0130 \u00dcRET\u0130M OLAN BU \u0130LA\u00c7LARIN F\u0130YATLANDIRILMASININ GER\u00c7EK MAL\u0130YETLER \u00dcZER\u0130NDEN YAPILMASINI \u0130ST\u0130YORUZ.<\/span><\/span><\/span><\/strong>\u0130\u015fte o zaman bug\u00fcn toplam 3,12 milyar YTL\u2019lik jenerik ila\u00e7 sat\u0131\u015f\u0131n\u0131n y\u00fczde 33 olan pazar pay\u0131, orijinal ila\u00e7lar geri \u00f6deme sistemine giremeyece\u011fi i\u00e7in bir anda %70\u2019lere gelecektir.<\/span> <\/span><\/span>\u00a0<\/span><\/p>\n

HAYD\u0130, T\u00dcRK ECZACILARI B\u0130RL\u0130\u011e\u0130,<\/span>\u00a0<\/span><\/span><\/p>\n

HAYD\u0130, \u0130LA\u00c7 END\u00dcSTR\u0130S\u0130 <\/span><\/span><\/p>\n

\u0130\u015eVERENLER\u0130 SEND\u0130KASI<\/span> <\/span><\/span><\/p>\n

\u00a0<\/span>HAYD\u0130, B\u00dcLENT ECZACIBA\u015eI,<\/span> <\/span><\/span>\u00a0<\/span><\/p>\n

VAR MISINIZ?<\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Sermayenin k\u00fcreselle\u015fmesi sonucu en \u00f6nemli sekt\u00f6rlerden biri olan uluslararas\u0131 ila\u00e7 sekt\u00f6r\u00fc \u00fclkemizi y\u0131llar \u00f6nce pazar\u0131 en fazla b\u00fcy\u00fcyecek \u00fc\u00e7 aday...<\/p>\n","protected":false},"author":18,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[50],"tags":[],"class_list":["post-2860","post","type-post","status-publish","format-standard","hentry","category-ecz-sedat-guclu"],"aioseo_notices":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/2860","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2860"}],"version-history":[{"count":1,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/2860\/revisions"}],"predecessor-version":[{"id":4001,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/2860\/revisions\/4001"}],"wp:attachment":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2860"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2860"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2860"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}